{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T21:40:03Z","timestamp":1734903603527,"version":"3.32.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,22]]},"DOI":"10.7759\/cureus.76208","type":"journal-article","created":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T21:18:53Z","timestamp":1734902333000},"source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Cellular DNA Content in Pleural Effusion by Flow Cytometry During Lung Cancer Progression: A Case Report"],"prefix":"10.7759","author":[{"given":"Maria M","family":"Vasilescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieta E","family":"Panait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirela","family":"Dumitru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.201305","article-title":"Diagnosis and management options in malignant pleural effusions","volume":"34","author":"Dixit R","year":"2017","unstructured":"Dixit R, Agarwal KC, Gokhroo A, Patil CB, Meena M, Shah NS, Arora P. Diagnosis and management options in malignant pleural effusions. Lung India. 2017, 34:160-6. 10.4103\/0970-2113.201305","journal-title":"Lung India"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55080490","article-title":"Malignant pleural effusion and its current management: a review","volume":"55","author":"Skok K","year":"2019","unstructured":"Skok K, Hladnik G, Grm A, Crnjac A. Malignant pleural effusion and its current management: a review. Medicina (Kaunas). 2019, 55:10.3390\/medicina55080490","journal-title":"Medicina (Kaunas)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00069812","article-title":"Survival of lung adenocarcinoma patients with malignant pleural effusion","volume":"41","author":"Wu SG","year":"2013","unstructured":"Wu SG, Yu CJ, Tsai MF, et al.. Survival of lung adenocarcinoma patients with malignant pleural effusion. Eur Respir J. 2013, 41:1409-18. 10.1183\/09031936.00069812","journal-title":"Eur Respir J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01254-2018","article-title":"Investigating unilateral pleural effusions: the role of cytology","volume":"52","author":"Arnold DT","year":"2018","unstructured":"Arnold DT, De Fonseka D, Perry S, et al.. Investigating unilateral pleural effusions: the role of cytology. Eur Respir J. 2018, 52:10.1183\/13993003.01254-2018","journal-title":"Eur Respir J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2012.063","article-title":"Flow cytometry method as a diagnostic tool for pleural fluid involvement in a patient with multiple myeloma","volume":"4","author":"Keklik M","year":"2012","unstructured":"Keklik M, Sivgin S, Pala C, et al.. Flow cytometry method as a diagnostic tool for pleural fluid involvement in a patient with multiple myeloma. Mediterr J Hematol Infect Dis. 2012, 4:e2012063. 10.4084\/MJHID.2012.063","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.9734\/IJMPCR\/2016\/26726","article-title":"Detection of metastatic lung cancer by immunocytochemistry and flow cytometry in a sample of pleural fluid","volume":"7","author":"Reis ML","year":"2016","unstructured":"Reis ML, Pilon R, Costa AB, et al.. Detection of metastatic lung cancer by immunocytochemistry and flow cytometry in a sample of pleural fluid. Int J Med Pharm Case Rep. 2016, 7:1-5. 10.9734\/IJMPCR\/2016\/26726","journal-title":"Int J Med Pharm Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.01.008","article-title":"Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models","volume":"18","author":"Sprouffske K","year":"2020","unstructured":"Sprouffske K, Kerr G, Li C, et al.. Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models. Comput Struct Biotechnol J. 2020, 18:323-31. 10.1016\/j.csbj.2020.01.008","journal-title":"Comput Struct Biotechnol J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3658","article-title":"Breast cancer intra-tumor heterogeneity","volume":"16","author":"Martelotto LG","year":"2014","unstructured":"Martelotto LG, Ng CK, Piscuoglio S, Weigelt B, Reis-Filho JS. Breast cancer intra-tumor heterogeneity. Breast Cancer Res. 2014, 16:210. 10.1186\/bcr3658","journal-title":"Breast Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01090-2","article-title":"Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy","volume":"14","author":"Venizelos A","year":"2022","unstructured":"Venizelos A, Engebrethsen C, Deng W, et al.. Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy. Genome Med. 2022, 14:86. 10.1186\/s13073-022-01090-2","journal-title":"Genome Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001789","article-title":"Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis","volume":"12","author":"Schwarz RF","year":"2015","unstructured":"Schwarz RF, Ng CK, Cooke SL, et al.. Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis. PLoS Med. 2015, 12:e1001789. 10.1371\/journal.pmed.1001789","journal-title":"PLoS Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(19)34118-2","article-title":"Prognostic significance of flow cytometry in non-small-cell lung cancer","volume":"106","author":"Rice TW","year":"1993","unstructured":"Rice TW, Bauer TW, Gephardt GN, Medendorp SV, McLain DA, Kirby TJ. Prognostic significance of flow cytometry in non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1993, 106:210-7. 10.1016\/S0022-5223(19)34118-2","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref12","article-title":"Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma","volume":"48","author":"Volm M","year":"1988","unstructured":"Volm M, Hahn EW, Mattern J, M\u00fcller T, Vogt-Moykopf I, Weber E. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res. 1988, 48:2923-8.","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.96.1.54","article-title":"Flow cytometric evaluation of bronchoscopic washings and lavage fluid for DNA aneuploidy as an adjunct in the diagnosis of lung cancer and tumors metastatic to the lung","volume":"96","author":"Yoss EB","year":"1989","unstructured":"Yoss EB, Berd D, Cohn JR, Peters SP. Flow cytometric evaluation of bronchoscopic washings and lavage fluid for DNA aneuploidy as an adjunct in the diagnosis of lung cancer and tumors metastatic to the lung. Chest. 1989, 96:54-9. 10.1378\/chest.96.1.54","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/thx.49.11.1152","article-title":"Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion","volume":"49","author":"Huang MS","year":"1994","unstructured":"Huang MS, Tsai MS, Hwang JJ, Wang TH. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion. Thorax. 1994, 49:1152-6. 10.1136\/thx.49.11.1152","journal-title":"Thorax"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S380016","article-title":"Clinical applications of aneuploidies in evolution of NSCLC patients: current status and application prospect","volume":"15","author":"Yan X","year":"2022","unstructured":"Yan X, Liu SM, Liu C. Clinical applications of aneuploidies in evolution of NSCLC patients: current status and application prospect. Onco Targets Ther. 2022, 15:1355-68. 10.2147\/OTT.S380016","journal-title":"Onco Targets Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.10.760","article-title":"Routine DNA cytometry of benign and malignant pleural effusions by means of the remote quantitation server Euroquant: a prospective study","volume":"53","author":"Kayser K","year":"2000","unstructured":"Kayser K, Blum S, Beyer M, Haroske G, Kunze KD, Meyer W. Routine DNA cytometry of benign and malignant pleural effusions by means of the remote quantitation server Euroquant: a prospective study. J Clin Pathol. 2000, 53:760-4. 10.1136\/jcp.53.10.760","journal-title":"J Clin Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2009506117","article-title":"Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division","volume":"117","author":"Replogle JM","year":"2020","unstructured":"Replogle JM, Zhou W, Amaro AE, et al.. Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division. Proc Natl Acad Sci U S A. 2020, 117:30566-76. 10.1073\/pnas.2009506117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2021.07.009","article-title":"Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies","volume":"56","author":"Lukow DA","year":"2021","unstructured":"Lukow DA, Sausville EL, Suri P, et al.. Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies. Dev Cell. 2021, 56:2427-39.e4. 10.1016\/j.devcel.2021.07.009","journal-title":"Dev Cell"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2021.07.006","article-title":"Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy","volume":"56","author":"Ippolito MR","year":"2021","unstructured":"Ippolito MR, Martis V, Martin S, et al.. Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy. Dev Cell. 2021, 56:2440-54.e6. 10.1016\/j.devcel.2021.07.006","journal-title":"Dev Cell"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/308927-analysis-of-cellular-dna-content-in-pleural-effusion-by-flow-cytometry-during-lung-cancer-progression-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T21:18:55Z","timestamp":1734902335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/308927-analysis-of-cellular-dna-content-in-pleural-effusion-by-flow-cytometry-during-lung-cancer-progression-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,22]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.76208","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,22]]}}}